Abstracts

Compensatory Mutations in HCV NS5A/B Coevolve in Patients Failing NS3 Inhibitors

Background: The monocistronic structure of HCV genome may imply a coevolution of all genes during protease inhibitors (PI) failure. Our aim was to analyze baseline to failure evolution of NS3/NS5A/NS5B in PI-failing patients. Methods: Twenty patients (15 GT1a; 5 GT1b) experiencing virological-failure with peg-IFN/riba+boceprevir (5), +telaprevir (13) or +simeprevir (2) were analyzed. NS3-protease, NS5A and…

Revaccinating HIV+ Adults With Double vs Standard HBV Regimen: ANRS B-BOOST Trial

Background: Immune response to standard hepatitis B (HBV) vaccination is decreased in HIV-infected patients, and it has been recently shown that a double dose HBV primary vaccination regimen improved serological response. However, the immunogenicity of this regimen in non responders to a previous vaccination is unknown. Methods: In an open-label, multicenter, 1:1 parallel groups randomized…

Higher Rate of Hepatitis B Antigen and Anti-HBV Antibody Seroconversion Among HIV/Chronic Hepatitis B Coinfection Initiating HBV Active HAART From Thailand

Background: Hepatitis B surface antigen (HBsAg) loss is considered the ideal outcome of chronic hepatitis B virus (HBV) infection. HBsAg loss was reported in 12% of subjects from a Caucasian HIV/HBV cohort. We investigated the rate and predictors of HBsAg loss and antiHBs Ab seroconversion among 213 HIV/HBV coinfected patients from Thailand. Methods: Subjects with…

Effect of Immunosuppression and Antivirals on Intracellular HBV Replication in HIV-HBV Coinfection

Background: Covalently closed circular DNA (ccc-DNA) of hepatitis B virus (HBV) acts as a reservoir for reactivation of viral replication and whose quantification can be used as a marker of persistent intracellular replication. The determinants of intracellular levels of replication have rarely been evaluated in HBV-human immunodeficiency virus (HIV) co-infected patients. Methods: Sixty HIV-HBV co-infected…